Novartis Q2 2024 Results Investor Presentation

Loading viewer...

earnings

Format: PDF earnings

Novartis presents Q2 2024 financial results and company overview as of July 18, 2024. The presentation covers financial review, strategic initiatives including the MorphoSys acquisition, and Novartis's transformation into a pure-play innovative medicines company following the Sandoz spin-off.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Novartis

View all →

2018_Case_Study_Novartis_Global_Environmental-Impact_WifOR

brochure

2018_Novartis_Social-Impact-ZA-and-Kenya_Case-Study_WifOR-4

brochure

Similar earningss from other companies

Browse all →

Builders FirstSource Q3 2016 Earnings Call

earnings

18 Pages

Builders FirstSource

Henlius 2024 Interim Results Investor Presentation

earnings